Leading Innovation in Blood Pressure

Our engineers, scientists, and mission-driven visionaries utilise unique datasets and deep learning algorithms, advancing beyond conventional blood pressure metrics to redefine proactive health standards.

We turn insights into action in the fight against hypertension

At Aktiia, we harness the power of data to inform and engage people with hypertension and to enable physicians to deliver more targeted and timely care.

Aktiia Co-Founders start working

Josep and Mattia join the Swiss Centre for Electronics and Microtechnology (CSEM)

Cuffless Blood Pressure R&D Process

30+ techniques tested, 10+ studies conducted;
1 proven solution: Optical Blood Pressure Monitoring

Josep Solà defends his PhD thesis

His research on continuous non-invasive BP estimation is the technology behind Aktiia’s monitoring solutions.

Aktiia is founded

Clinical Trial Confirms Accuracy of Cuffless BP Monitoring

Aktiia’s clinical trial, highlighted in Blood Pressure Monitoring journal, demonstrates its optical device’s accuracy in measuring blood pressure without cuffs, compared to traditional arterial line methods.

Aktiia's Clinical Trial Validates Cuffless BP Monitoring Versus Auscultation

Aktiia’s trial successfully compares its cuffless BP monitoring technology against traditional auscultation methods, ensuring accuracy during posture changes. This supports the device’s use for consistent 24-hour blood pressure tracking.

Aktiia earns the CE mark

Aktiia is classified as a Class IIa Medical Device, adhering to the highest safety and performance standards in the European Union.

Aktiia debuts in the UK Market

Aktiia continues its expansion, offering its advanced health monitoring technologies to the UK audience.

1 Million Readings

Aktiia launches in Six European Markets

Aktiia brings its cutting-edge solution to Germany, Switzerland, France, Italy, Austria and Ireland.

120 Million Readings

Nature Cardiology Reviews features Aktiia data

600 Million Readings

Nature Publication Validates Aktiia's Blood Pressure Monitor Accuracy

Published in Nature Scientific Reports, Aktiia’s study demonstrates the consistent accuracy of its wearable blood pressure monitor across different body positions.

900 Million Readings

1.5 Billion Readings

Aktiia Study in Nature Shows Cuffless Monitor on Par with 24-h Daytime ABPM

Aktiia’s cuffless BP monitor is validated by a Nature Hypertension study, showing equivalent accuracy to 24-hour ambulatory monitoring in cardiac rehab patients.

3 Billion Readings

4.5 Billion Readings

Study of Aktiia device in the elderly

Evaluating its performance in different body positions with auscultation as the reference measurement.

Aktiia's Global Research Footprint Expands

Aktiia’s blood pressure technology is at the forefront of medical innovation, participating in over 20 clinical trials worldwide to improve patient care and health outcomes.

6 Billion Readings

Regulatory Approval for the World’s First Optical Blood Pressure System Without the Need for Calibration with a Regular Cuff

Approval of the CALFREE™ technology sets the stage for Aktiia to transform BP monitoring and management.

Aktiia Appoints Industry Veteran Rags Gupta as New CEO

We’re excited to announce the appointment of Raghav “Rags” Gupta as the new CEO. With a wealth of experience and a proven track record, Rags brings a dynamic leadership style that aligns perfectly with Aktiia’s mission to transform blood pressure monitoring and management globally.

It’s our mission to transform this data into programs and service that will help people live their lives free from hypertension.

The unique data from Aktiia’s automated 24/7 blood pressure solution leads to never-before-possible insights about cardiovascular health.

Aktiia’s team of experts has:

4 PhD’s in biomedical signal processing

Over 120 peer-reviewed publications

Over 35 collective patents

Member of ISO/IEEE committees

Editor of "Cuffless Blood Pressure Handbook"

Rags Gupta
CEO
Seasoned tech entrepreneur with a proven track record in growth and commercialization. Author of the bestselling book “One to Ten: Finding Your Way from Startup to Scaleup”
Josep Solà
CTO
Ph.D. in Telecommunications from the Swiss Federal Institute of Technology in Zurich. Editor of the book “The Handbook of Cuffless Blood pressure Monitoring - A practical guide for clinicians, researchers, and engineers“ published by Springer
Jay Shah MD FACC
Chief Medical Officer
Practicing cardiovascular disease expert with 17+ years expertise. Previously Mayo Clinic, Mass General
Mattia Bertschi
COO
Ph.D. in Biomedical Engineering from the Swiss Federal Institute of Technology in Lausanne
Neil Puri
Head of Quality & Regulatory
15+ years in regulated industries. Held multiple leadership roles at Dexcom
Mathieu Danthony
Head of Finance
MS in Finance, CPA, 13+ years of international finance experience
Daniel Graf
President
Independent board member. Previously at Google, Uber, Twitter, Dispatch Health

Advised by:

Dr. Grégoire Wuerzner
Principal Investigator of the pivotal validation studies, CHUV, Switzerland
M.D. Bruce S. Alpert
Plough Foundation Chair of Excellence, U of TN. American Heart Association Fellow
Naomi Fisher
Director, Hypertension Service at Brigham and Women's Hospital Associate Professor, Harvard Medical School